|
Market Closed -
London S.E.
16:35:18 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 72.50 GBX | 0.00% |
|
-18.08% | -9.94% |
| 09-30 | Arecor Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 09-30 | EARNINGS: Arecor fundraise as loss widens; Northcoders' B2B progress | AN |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | -18.08% | -2.03% | +14.17% | -9.94% | -16.18% | -62.34% | -80.92% | - | 36.16M | |
| +4.16% | +3.04% | +8.38% | +33.66% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.41B | |
| -3.11% | -3.53% | -9.46% | -1.19% | +13.76% | +21.92% | +74.60% | +218.02% | +5,289.29% | 59.26B | |
| +0.89% | -0.63% | -3.05% | +0.18% | +5.17% | +4.28% | +34.51% | -18.05% | +203.27% | 47.14B | |
| -0.78% | -4.35% | -1.99% | +24.90% | +14.72% | +26.55% | +33.38% | +8.40% | +222.44% | 42.91B | |
| -0.04% | +0.35% | -1.70% | +8.69% | +158.23% | +350.07% | +685.94% | +619.16% | - | 44.13B | |
| -1.62% | -2.29% | -2.54% | +18.45% | +16.05% | +2.15% | +97.52% | -0.35% | +1,037.35% | 40.79B | |
| -0.54% | +2.93% | -2.87% | +4.64% | +5.93% | +9.50% | +50.41% | -10.44% | +144.22% | 30.77B | |
| -2.68% | +5.11% | +10.25% | +57.66% | +73.51% | +33.11% | +19.50% | -56.88% | - | 29.31B | |
| +1.11% | -7.13% | -13.58% | -1.94% | -37.12% | -28.38% | +331.34% | +313.57% | +651.58% | 23.71B | |
| -0.39% | -1.88% | -6.88% | -0.90% | +1.54% | -7.51% | -14.27% | -61.16% | - | 24.33B | |
| -2.42% | -0.88% | +3.77% | +20.44% | +11.35% | +11.46% | -7.65% | -17.11% | +97.64% | 20.81B | |
| +0.85% | -2.31% | +1.95% | +8.42% | +7.64% | +12.76% | +149.24% | +215.70% | +1,880.23% | 16.69B | |
| -0.43% | +0.87% | -11.07% | -4.98% | +174.96% | +131.18% | +326.82% | +1,692.64% | +635.44% | 15.17B | |
| +0.31% | +0.83% | -14.90% | -17.13% | - | - | - | - | - | 14.93B | |
| -3.04% | +1.33% | -3.59% | +8.25% | +20.40% | -8.13% | +516.45% | - | - | 14.84B | |
| +0.43% | -3.23% | +2.86% | +8.27% | +19.97% | +19.13% | +43.03% | -28.54% | +81.88% | 14.57B | |
| +0.60% | -9.35% | +24.42% | +27.87% | +30.51% | -13.70% | - | - | - | 13.8B | |
| +0.46% | +0.19% | -0.44% | +4.33% | +32.95% | +40.92% | +162.24% | +176.95% | +358.10% | 14.36B | |
| +0.64% | -1.30% | -0.93% | +25.29% | +44.90% | +64.83% | +49.46% | -27.46% | +245.41% | 13.69B | |
| Average | -0.28% | -2.07% | -1.17% | +11.95% | +35.22% | +37.02% | +143.58% | +173.71% | +903.90% | 27.78B | |
| Weighted average by Cap. | -0.11% | -0.77% | -1.07% | +13.83% | +41.13% | +48.35% | +146.04% | +146.60% | +1,316.69% |
- Stock Market
- Stocks
- AREC Stock
- Sector Arecor Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
